Copyright Reports & Markets. All rights reserved.

Global Cardiovascular Implants Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cardiovascular Implants Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cardiovascular Implants Market Size Growth Rate by Product
      • 1.4.2 Coronary Stents
      • 1.4.3 Peripheral Stents
      • 1.4.4 Heart Valves
      • 1.4.5 Implanted Cardiac Pacemakers
      • 1.4.6 Implantable Cardioverter Defibrillator
      • 1.4.7 Cardiac Resynchronization Therapy (CRT) Device
    • 1.5 Market by End User
      • 1.5.1 Global Cardiovascular Implants Market Size Growth Rate by End User
      • 1.5.2 Minimally Invasive Heart Surgery
      • 1.5.3 Heart Valve Repair or Replacement
      • 1.5.4 Cardiac Resynchronization Therapy (CRT)
      • 1.5.5 Open Heart Surgery
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cardiovascular Implants Market Size
      • 2.1.1 Global Cardiovascular Implants Revenue 2014-2025
      • 2.1.2 Global Cardiovascular Implants Sales 2014-2025
    • 2.2 Cardiovascular Implants Growth Rate by Regions
      • 2.2.1 Global Cardiovascular Implants Sales by Regions
      • 2.2.2 Global Cardiovascular Implants Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cardiovascular Implants Sales by Manufacturers
      • 3.1.1 Cardiovascular Implants Sales by Manufacturers
      • 3.1.2 Cardiovascular Implants Sales Market Share by Manufacturers
      • 3.1.3 Global Cardiovascular Implants Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiovascular Implants Revenue by Manufacturers
      • 3.2.1 Cardiovascular Implants Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiovascular Implants Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cardiovascular Implants Price by Manufacturers
    • 3.4 Cardiovascular Implants Manufacturing Base Distribution, Product Types
      • 3.4.1 Cardiovascular Implants Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cardiovascular Implants Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cardiovascular Implants Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cardiovascular Implants Sales by Product
    • 4.2 Global Cardiovascular Implants Revenue by Product
    • 4.3 Cardiovascular Implants Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cardiovascular Implants Breakdown Data by End User

    6 North America

    • 6.1 North America Cardiovascular Implants by Countries
      • 6.1.1 North America Cardiovascular Implants Sales by Countries
      • 6.1.2 North America Cardiovascular Implants Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cardiovascular Implants by Product
    • 6.3 North America Cardiovascular Implants by End User

    7 Europe

    • 7.1 Europe Cardiovascular Implants by Countries
      • 7.1.1 Europe Cardiovascular Implants Sales by Countries
      • 7.1.2 Europe Cardiovascular Implants Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cardiovascular Implants by Product
    • 7.3 Europe Cardiovascular Implants by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cardiovascular Implants by Countries
      • 8.1.1 Asia Pacific Cardiovascular Implants Sales by Countries
      • 8.1.2 Asia Pacific Cardiovascular Implants Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cardiovascular Implants by Product
    • 8.3 Asia Pacific Cardiovascular Implants by End User

    9 Central & South America

    • 9.1 Central & South America Cardiovascular Implants by Countries
      • 9.1.1 Central & South America Cardiovascular Implants Sales by Countries
      • 9.1.2 Central & South America Cardiovascular Implants Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cardiovascular Implants by Product
    • 9.3 Central & South America Cardiovascular Implants by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cardiovascular Implants by Countries
      • 10.1.1 Middle East and Africa Cardiovascular Implants Sales by Countries
      • 10.1.2 Middle East and Africa Cardiovascular Implants Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cardiovascular Implants by Product
    • 10.3 Middle East and Africa Cardiovascular Implants by End User

    11 Company Profiles

    • 11.1 Abbott Laboratories
      • 11.1.1 Abbott Laboratories Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Laboratories Cardiovascular Implants Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Laboratories Cardiovascular Implants Products Offered
      • 11.1.5 Abbott Laboratories Recent Development
    • 11.2 Boston Scientific
      • 11.2.1 Boston Scientific Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Boston Scientific Cardiovascular Implants Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Boston Scientific Cardiovascular Implants Products Offered
      • 11.2.5 Boston Scientific Recent Development
    • 11.3 Medtronic
      • 11.3.1 Medtronic Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Medtronic Cardiovascular Implants Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Medtronic Cardiovascular Implants Products Offered
      • 11.3.5 Medtronic Recent Development
    • 11.4 St. Jude Medical
      • 11.4.1 St. Jude Medical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 St. Jude Medical Cardiovascular Implants Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 St. Jude Medical Cardiovascular Implants Products Offered
      • 11.4.5 St. Jude Medical Recent Development

    12 Future Forecast

    • 12.1 Cardiovascular Implants Market Forecast by Regions
      • 12.1.1 Global Cardiovascular Implants Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cardiovascular Implants Revenue Forecast by Regions 2019-2025
    • 12.2 Cardiovascular Implants Market Forecast by Product
      • 12.2.1 Global Cardiovascular Implants Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cardiovascular Implants Revenue Forecast by Product 2019-2025
    • 12.3 Cardiovascular Implants Market Forecast by End User
    • 12.4 North America Cardiovascular Implants Forecast
    • 12.5 Europe Cardiovascular Implants Forecast
    • 12.6 Asia Pacific Cardiovascular Implants Forecast
    • 12.7 Central & South America Cardiovascular Implants Forecast
    • 12.8 Middle East and Africa Cardiovascular Implants Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cardiovascular Implants Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.
      The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
      The global Cardiovascular Implants market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiovascular Implants market based on company, product type, end user and key regions.

      This report studies the global market size of Cardiovascular Implants in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiovascular Implants in these regions.
      This research report categorizes the global Cardiovascular Implants market by top players/brands, region, type and end user. This report also studies the global Cardiovascular Implants market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott Laboratories
      Boston Scientific
      Medtronic
      St. Jude Medical

      Market size by Product
      Coronary Stents
      Peripheral Stents
      Heart Valves
      Implanted Cardiac Pacemakers
      Implantable Cardioverter Defibrillator
      Cardiac Resynchronization Therapy (CRT) Device
      Market size by End User
      Minimally Invasive Heart Surgery
      Heart Valve Repair or Replacement
      Cardiac Resynchronization Therapy (CRT)
      Open Heart Surgery
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cardiovascular Implants market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cardiovascular Implants market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cardiovascular Implants companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cardiovascular Implants submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cardiovascular Implants are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiovascular Implants market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now